Higashi Y, Kawamura J, Kanamaru H, Kakehi Y, Yoshida O
Hinyokika Kiyo. 1984 May;30(5):599-607.
Twenty cases (3.3%) of hypercalcemia of more than 11.0 mg/dl associated with urogenital malignancy were observed in 610 inpatients during the past 5 years and 6 months (Jan. 1978-June 1983). Incidences were 10 (16.1%) out of 62 cases of renal cell carcinoma, 6 (1.9%) out of 321 cases of bladder cancer, 3 (6.7%) out of 45 cases of renal pelvic and ureteral cancer, and one (1.1%) out of 95 cases of prostatic cancer. As treatment, surgery (radical nephrectomy) and anti-cancer chemotherapy were effective in 3 cases (2 renal cell carcinomas and one renal pelvic cancer). Conservative therapy with hydration combined with either indomethacin, steroid or eel calcitonin was effective in 11 cases, and s-Ca level was decreased by 3.7 mg/dl on the average. Eighteen patients were in the terminal stage of malignancy when hypercalcemia was observed, and died 5 days to 9 months (mean; 2 months) after the onset of hypercalcemia.
在过去5年6个月(1978年1月至1983年6月)的610例住院患者中,观察到20例(3.3%)血钙超过11.0mg/dl且与泌尿生殖系统恶性肿瘤相关的高钙血症病例。在62例肾细胞癌患者中有10例(16.1%),在321例膀胱癌患者中有6例(1.9%),在45例肾盂和输尿管癌患者中有3例(6.7%),在95例前列腺癌患者中有1例(1.1%)。作为治疗方法,手术(根治性肾切除术)和抗癌化疗对3例有效(2例肾细胞癌和1例肾盂癌)。水化联合吲哚美辛、类固醇或鳗鱼降钙素的保守治疗对11例有效,血清钙水平平均下降3.7mg/dl。18例患者在观察到高钙血症时已处于恶性肿瘤晚期,在高钙血症发作后5天至9个月(平均2个月)死亡。